How have REVIVED (percutaneous revascularization for ischemic left ventricular dysfunction) results changed my practice?

PCR Perspectives

Summary

Mirvat Alasnag and Ajay Kirtane reflect on the REVIVED (percutaneous revascularization for ischemic left ventricular dysfunction) randomised trial 9 months after its release. They discuss how the unexpected results had an effect on their practice, and how results compare to those of the STICH trial.